YIPF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.597440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.058300E-02
Normal-vs-Stage2
1.509980E-01
Normal-vs-Stage3
5.740000E-01
Normal-vs-Stage4
1.886200E-01
Stage1-vs-Stage2
7.457400E-01
Stage1-vs-Stage3
5.932000E-02
Stage1-vs-Stage4
5.031000E-01
Stage2-vs-Stage3
2.077200E-01
Stage2-vs-Stage4
2.289000E-01
Stage3-vs-Stage4
2.122200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.673430E-01
Normal-vs-AfricanAmerican
7.078400E-02
Normal-vs-Asian
4.024200E-01
Caucasian-vs-AfricanAmerican
3.105800E-01
Caucasian-vs-Asian
5.100600E-01
AfricanAmerican-vs-Asian
2.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.610640E-01
Normal-vs-Female
1.683160E-01
Male-vs-Female
8.207800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.824170E-01
Normal-vs-Age(41-60Yrs)
9.074200E-02
Normal-vs-Age(61-80Yrs)
2.010200E-01
Normal-vs-Age(81-100Yrs)
3.028600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.665200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.276200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.409800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.541600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.782000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.777600E-01
Normal-vs-Daily Drinker
4.231800E-01
Normal-vs-Weekly Drinker
2.829200E-01
Normal-vs-Occasional Drinker
8.886000E-02
Normal-vs-Social Drinker
1.450830E-01
Non Drinker-vs-Daily Drinker
5.707200E-01
Non Drinker-vs-Weekly Drinker
7.636800E-01
Non Drinker-vs-Occasional Drinker
3.569500E-02
Non Drinker-vs-Social Drinker
2.620200E-01
Daily Drinker-vs-Weekly Drinker
8.415000E-01
Daily Drinker-vs-Occasional Drinker
3.489700E-02
Daily Drinker-vs-Social Drinker
1.902760E-01
Weekly Drinker-vs-Occasional Drinker
7.028300E-02
Weekly Drinker-vs-Social Drinker
2.698400E-01
Occasional Drinker-vs-Social Drinker
4.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.652960E-01
Normal-vs-Grade 2
5.568000E-02
Normal-vs-Grade 3
2.845700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.898800E-01
Grade 1-vs-Grade 3
1.557820E-01
Grade 1-vs-Grade 4
1.652960E-01
Grade 2-vs-Grade 3
3.703600E-01
Grade 2-vs-Grade 4
5.568000E-02
Grade 3-vs-Grade 4
2.845700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.761560E-01
Normal-vs-NonDiabetic
1.950010E-01
Diabetic-vs-NonDiabetic
5.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.179800E-02
Normal-vs-NoPancreatitis
1.772810E-01
Pancreatitis-vs-NoPancreatitis
4.506400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.800640E-01
Normal-vs-N1
1.581770E-01
N0-vs-N1
6.249000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.977900E-02
Normal-vs-TP53-NonMutant
1.290820E-01
TP53-Mutant-vs-TP53-NonMutant
1.023190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
